)
Edge6 Mar 2026
Upvoted: The Story of Reddit
How Reddit built a unique platform around communities and conversation, turning human insight and intent into a distinctive business model.
Curis
Curis (CRIS) investor relations material
Curis Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary19 Mar, 2026
Executive summary
Achieved net income of $19.4 million in Q4 2025, reversing a net loss of $9.6 million in Q4 2024, driven by a $27.2 million non-cash gain from the sale of Erivedge royalties.
Full-year 2025 net loss narrowed to $7.6 million from $43.4 million in 2024, reflecting lower R&D and G&A expenses.
Advanced clinical programs for emavusertib in PCNSL, SCNSL, CLL, and AML, with promising early efficacy and MRD conversion data.
Financial highlights
Q4 2025 revenues were $1.1 million, down from $3.3 million in Q4 2024, due to the sale of Erivedge royalty rights.
Research and development expenses decreased to $5.8 million in Q4 2025 from $9.0 million in Q4 2024; full-year R&D was $28.3 million, down from $38.6 million.
General and administrative expenses fell to $2.9 million in Q4 2025 from $3.4 million in Q4 2024; full-year G&A was $14.0 million, down from $16.8 million.
Recognized a $27.2 million non-cash gain in Q4 2025 from the release of liability related to the sale of future royalties.
Cash and cash equivalents were $5.1 million as of December 31, 2025, with 12.9 million shares outstanding.
Outlook and guidance
Cash runway expected into the second half of 2027, assuming exercise of Series B warrants from the January 2026 PIPE financing.
Ongoing enrollment in TakeAim Lymphoma and CLL studies, with regulatory filings for accelerated approval in PCNSL targeted in the US and Europe.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Curis
- Shareholders to vote on share increase, PIPE-related issuances, and a new equity incentive plan.CRIS
Proxy Filing19 Feb 2026 - Registers 107.7M shares for resale by PIPE investors; no proceeds to company; clinical-stage biotech.CRISRegistration Filing13 Feb 2026
- Shareholders to vote on major share increase, PIPE-related issuances, and a new incentive plan.CRISProxy Filing9 Feb 2026
- Emavusertib gains EU ODD as Q2 net loss hits $11.8M; cash runway extends into Q1 2025.CRISQ2 20242 Feb 2026
- Emavusertib delivers strong early results in NHL and AML, with expansion into solid tumors underway.CRISH.C. Wainwright 26th Annual Global Investment Conference 202420 Jan 2026
- Promising IRAK4 inhibitor data in AML and NHL drive pivotal trial plans and partnership interest.CRIS2024 Cantor Fitzgerald Global Healthcare Conference20 Jan 2026
- Q3 net loss narrowed, emavusertib data positive, but cash only funds operations into mid-2025.CRISQ3 202414 Jan 2026
- Emavusertib demonstrates superior efficacy and safety in PCNSL and AML, with broad expansion planned.CRISH.C. Wainwright 27th Annual Global Investment Conference27 Dec 2025
- Emavusertib advanced toward accelerated approval with strong data and extended cash runway, but funding risks remain.CRISQ4 202426 Dec 2025
Next Curis earnings date
Q1 20265 May, 2026
Curis
Next Curis earnings date
Q1 20265 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage